Target intelligence / Profile preview

Complement system components and fragments

Molecular classification
Enzyme, Receptor, Serum protein, Protease
01

Overview

The complement system is a complex network of over 30 plasma and cell-surface proteins that play a critical role in the innate immune response. It functions through three primary pathways—classical, lectin, and alternative—which converge on the cleavage of C3 and subsequently C5, leading to the formation of the membrane attack complex (MAC) and the release of potent inflammatory mediators like C3a and C5a [1][2]. Dysregulation of these components is implicated in various rare and common diseases, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and age-related macular degeneration [3][4]. Therapeutic strategies involve targeting specific fragments or enzymes within the cascade, such as C5 inhibitors (e.g., eculizumab) or C3 inhibitors (e.g., pegcetacoplan), to prevent tissue damage and hemolysis [5]. While highly effective, blocking these pathways significantly increases the risk of life-threatening infections by encapsulated bacteria, necessitating prophylactic vaccination [6].

Other names
Complement cascadeComplement proteinsComplement factorsComplement system
02

Biological functions

Immune responseInflammationOpsonizationCell lysisPhagocytosisChemotaxis
03

Disease associations

Paroxysmal nocturnal hemoglobinuriaAtypical hemolytic uremic syndromeMyasthenia gravisAge-related macular degenerationSystemic lupus erythematosusNeuromyelitis optica spectrum disorderC3 glomerulopathy
04

Safety considerations

Increased susceptibility to encapsulated bacterial infections (especially Neisseria meningitidis)Risk of autoimmune-like reactionsInfusion-related reactionsPotential for rebound hemolysis upon discontinuation
05

Interacting drugs

Eculizumab

7 more in the full profile.

06

Biomarkers

CH50 (Total Complement Activity)C3 levelsC4 levelsSoluble C5b-9 (sMAC)C5a levelsBb fragment

Beyond the preview

Go deeper on Complement system components and fragments.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement system components and fragments.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call